Company intelligence / Profile preview

Otto Sciences

Nuremberg, Bavaria, Germanyottosciences.com ↗

Ownership: Private
Employees: ~140
Development stage: Commercial

Overview

OTTO Life Science Engineering GmbH specializes in turnkey engineering, procurement, and construction (EPC) solutions for pharmaceutical and biotech production facilities. The company covers the full value chain from planning to requalification of cleanrooms and labs. It has a strong track record with high-value clients in pharma/biotech manufacturing. In July 2024 it was announced that SPIE would acquire an 87% stake in the company.

Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Otto Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Otto Sciences.

Explore the full profile